Abstract PS2-21: Analysis of the clinical applicability of modified residual cancer burden system in evaluating the pathological response of breast cancer after neoadjuvant treatment
2021
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI